IngentaConnect Search Results

Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation

Authors: Keller, Guillermo A.; Ponte, Marcelo L.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 105-111(7)

Publisher: Bentham Science Publishers

A review on the treatment of relapsed/metastatic head and neck cancer

Authors: Ferrari, Daris; Codecà, Carla; Fiore, Jessica; Luciani, Andrea; Foa, Paolo

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 16, November 2009 , pp. 2625-2632(8)

Publisher: Informa Healthcare

Bleomycin/cisplatin/etoposide: Small bowel perforation: case report

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 11-11(1)

Publisher: Adis International

Cisplatin: Ventricular tachycardia following intraperitoneal administration in an elderly patient: case report

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 13-13(1)

Publisher: Adis International

Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma

Authors: Möller, Mecker G; Salwa, Slawomir; Soden, Declan M; O'Sullivan, Gerald C

Source: Expert Review of Anticancer Therapy, Volume 9, Number 11, November 2009 , pp. 1611-1630(20)

Publisher: Expert Reviews

The cost utility of pemetrexed as first-line therapy for advanced non-small cell lung cancer appears to be hindered by poor basal QOL

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 8-8(1)

Publisher: Adis International

Status of Non-Classical Mononuclear Platinum Anticancer Drug Development

Authors: Zhang, Jinchao; Liu, Dandan; Li, Yaping; Sun, Jing; Wang, Liwei; Zang, Aimin

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 11, October 2009 , pp. 1357-1366(10)

Publisher: Bentham Science Publishers

Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: Therapeutic potential for ovarian cancer

Authors: Zhang, Ning; Wu, Zhen-Ming; McGowan, Eileen; Shi, Jun; Hong, Zu-Bei; Ding, Chuan-Wei; Xia, Pu; Di, Wen

Source: Cancer Science, Volume 100, Number 12, December 2009 , pp. 2459-2464(6)

Publisher: Blackwell Publishing

Cisplatin Overdose: Toxicities and Management

Authors: Tsang, Roger Y.; Al-Fayea, Turki; Au, Heather-Jane

Source: Drug Safety, Volume 32, Number 12, 1 December 2009 , pp. 1109-1122(14)

Publisher: Adis International

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Authors: Ruhstaller, T.; Widmer, L.; Schuller, J. C.; Roth, A.; Hess, V.; Mingrone, W.; von Moos, R.; Borner, M.; Pestalozzi, B. C.; BalmerMajno, S.; Kberle, D.; Terraciano, L.; Schnider, A.; Bodis, S.; Popescu, R.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1522-1528(7)

Publisher: Oxford University Press

Anaplastic astroblastoma of childhood: aggressive behavior

Authors: Kantar, M.; Ertan, Y.; Turhan, T.; Kitis, O.; Anacak, Y.; Akalin, T.; Ersahin, Y.; Cetingül, N.

Source: Child's Nervous System, Volume 25, Number 9, September 2009 , pp. 1125-1129(5)

Publisher: Springer

Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma

Authors: Wongkham, Sopit; Junking, Mutita; Wongkham, Chaisiri; Sripa, Banchob; Chur-in, Siri; Araki, Norie

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2077-2084(8)

Publisher: Blackwell Publishing

Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis

Authors: Na, Yi-Rang; Seok, Seung-Hyeok; Kim, Dong-Jae; Han, Ju-Hee; Kim, Tae-Hyoun; Jung, Hyun; Lee, Byoung-Hee; Park, Jae-Hak

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2218-2225(8)

Publisher: Blackwell Publishing

Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial

Authors: Rivera, Fernando; García-Castaño, Almudena; Vega, Noelia; Vega-Villegas, Maria Eugenia; Gutiérrez-Sanz, Lourdes

Source: Expert Review of Anticancer Therapy, Volume 9, Number 10, October 2009 , pp. 1421-1428(8)

Publisher: Expert Reviews

Carboplatin/cisplatin/paclitaxel: GI and bone marrow toxicity, blood dyscrasias and regression of pulmonary metastases to pneumatoceles: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 15-15(1)

Publisher: Adis International

Carboplatin/cisplatin/etoposide: Intestinal perforation in an elderly patient: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 15-15(1)

Publisher: Adis International

Cisplatin/ifosfamide: Renal impairment, pancytopenia, hearing loss and encephalopathy: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 17-17(1)

Publisher: Adis International

The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines

Authors: Perry, Jackie; Powles, Thomas; Shamash, Jonathan; Veerupillai, Arthi; McGrowder, Eva; Noel, Elodie; Lu, Yong-Jie; Oliver, Tim; Joel, Simon

Source: Cancer Chemotherapy and Pharmacology, Volume 64, Number 5, October 2009 , pp. 925-933(9)

Publisher: Springer

A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment

Authors: Marcu, Loredana; Yeoh, E.

Source: Journal of Cancer Research and Clinical Oncology, Volume 135, Number 10, October 2009 , pp. 1303-1314(12)

Publisher: Springer

Cross-linking to an interrupted polypurine sequence with a platinum-modified triplex-forming oligonucleotide

Authors: Campbell, Meghan; Miller, Paul

Source: JBIC Journal of Biological Inorganic Chemistry, Volume 14, Number 6, August 2009 , pp. 873-881(9)

Publisher: Springer